𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Computed tomography in the staging of small cell lung cancer: Implications for combined modality therapy

✍ Scribed by John D. Norlund; Roger W. Byhardt; W.Dennis Foley; George F. Unger; James D. Cox

Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
512 KB
Volume
11
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined modality therapy for stage IIIM
Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience
✍ Patricia J. Madej; Jacob D. Bitran; Harvey M. Golomb; Philip G. Hoffman Jr; Thom πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 720 KB

Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w

Results of combined-modality therapy for
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly
✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

The value of combined-modality therapy i
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer
✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l